Marc Webster

发表

Primary results of ROSE/TRIO-12, a randomized placebo-controlled phase III trial evaluating the addition of ramucirumab to first-line docetaxel chemotherapy in metastatic breast cancer.

A. Manikhas, G. Konecny, V. Semiglazov, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.